Accessibility: Skip TopNav
REDWOOD-HCM Cohort 3
REDWOOD-HCM Cohort 3: evidence for clinical efficacy of aficamten patients with obstructive HCM and HF symptoms refractory to maximal medical therapy, including disopyramide
Format
JPEG
Source
Cytokinetics, Incorporated
Downloads
Original
Large
Medium
Small